Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. senator asks J&J for documents on talc, baby powder safety

Published 01/29/2019, 02:40 PM
Updated 01/29/2019, 02:40 PM
© Reuters. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California

(Reuters) - U.S. Democratic Senator Patty Murray sent a letter to Johnson & Johnson (NYSE:JNJ) on Tuesday seeking information related to allegations in a Reuters Special Report that the healthcare company knew about the presence of asbestos in its talc-based baby powder.

The letter addressed to J&J Chief Executive Alex Gorsky asks for documents and information related to testing of its talc products for the presence of carcinogens and "how it presented that information to regulators and consumers."

Reuters on Dec. 14 published a Special Report detailing that the company knew that the talc in its raw and finished powders sometimes tested positive for cancer-causing asbestos from the 1970s into the early 2000s - test results the company did not disclose to regulators or consumers.

While exposure to asbestos has been linked to mesothelioma, J&J has repeatedly said that its talc products are safe, and that decades of studies have shown them to be asbestos-free and that they do not cause cancer.

J&J spokesman Ernie Knewitz, in an emailed statement, acknowledged receiving the letter and said the company looks forward to sharing its response with the senator.

“As we have consistently stated, we firmly stand behind the safety and purity of our talc, which has been confirmed by thousands of independent tests by regulators worldwide, including the U.S. FDA and many of the world’s leading independent laboratories," the company statement said.

Murray, the top Democrat on the Republican-controlled Senate Committee on Health, Education, Labor and Pensions, referred to the Reuters report in her letter. It began, "I am troubled by recent reports of an alleged decades-long effort by Johnson & Johnson to potentially mislead regulators and consumers about the safety of one of its products, which may have resulted in long-term harm for men, women, and children who used Johnson & Johnson baby powder."

J&J is facing more than 11,000 lawsuits alleging that use of its talc products, including baby powder, caused cancer.

© Reuters. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California

Murray asked for documents to support the company's claim that its current talc products do not contain any level of asbestos, documents on the testing of its talc products and communications with the Food and Drug Administration about the safety of its baby powder dating from 1966 to present.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.